Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective
- PMID: 22698711
- DOI: 10.1016/j.ejrad.2012.05.006
Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective
Abstract
Objectives: The remarkable morbidity and mortality of lung cancer in the large population address major economic challenges to Chinese healthcare system. This study aims to assess the cost-effectiveness of fluorodeoxyglucose positron emission tomography (FDG PET)/CT for staging patients with non-small cell lung cancer (NSCLC) in China.
Methods: Management of potentially operative NSCLC was modeled on decision analysis employing data in China. The strategies compared were conventional CT staging (strategy A), additional PET/CT in all patients (strategy B) or only in patients with normal-sized lymph nodes on CT (strategy C). Published medical data for Chinese patients was extracted. The costs corresponded to reimbursement by Chinese public health provider in 2010. Uncertainly of employed parameters was calculated in sensitivity analysis.
Results: Taking strategy A as baseline, the incremental cost-effectiveness ratio (ICER) of strategy B was 23,800RMB ($3500) per life year saved, which was acceptable in views of a developing country as China; while strategy C exhibited some loss of life years. Sensitivity analysis suggested the ICER (B-A) was raised more remarkably by a deterioration of PET specificity than by that of its sensitivity. The ICER was turned negative by PET specificity lower than 0.79. Economically, PET cost was proportional to the ICER (B-A), and decrease of palliative therapy cost could reduce both the ICER and overall cost.
Conclusions: The PET/CT strategy is potentially cost-effective for management of NSCLC in China. Patients with nodal-positive CT results are not suggested to be excluded from further PET/CT. Furthermore, maintaining high specificity of PET in clinical scenarios is crucial. Prospective trials are warranted to transfer these results into policy making.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.Q J Nucl Med Mol Imaging. 2007 Sep;51(3):224-34. Epub 2007 Jun 1. Q J Nucl Med Mol Imaging. 2007. PMID: 17538525
-
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Eur J Cardiothorac Surg. 2009. PMID: 19464906 Review.
-
Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?J Surg Res. 2012 Nov;178(1):304-14. doi: 10.1016/j.jss.2012.03.074. Epub 2012 Apr 22. J Surg Res. 2012. PMID: 22541065
-
The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.Value Health. 2013 Jan-Feb;16(1):57-65. doi: 10.1016/j.jval.2012.09.007. Value Health. 2013. PMID: 23337216
-
Management of advanced lung cancer in resource-constrained settings: a perspective from India.Expert Rev Anticancer Ther. 2012 Nov;12(11):1479-95. doi: 10.1586/era.12.119. Expert Rev Anticancer Ther. 2012. PMID: 23249112 Review.
Cited by
-
Functional imaging for interpretation of pain pathways: current clinical application/relevance and future initiatives.Curr Pain Headache Rep. 2013 Feb;17(2):311. doi: 10.1007/s11916-012-0311-x. Curr Pain Headache Rep. 2013. PMID: 23315051 Review.
-
Optimal sequence of tests for the mediastinal staging of non-small cell lung cancer.BMC Med Inform Decis Mak. 2016 Jan 26;16:9. doi: 10.1186/s12911-016-0246-y. BMC Med Inform Decis Mak. 2016. PMID: 26813400 Free PMC article.
-
Cost-effectiveness analysis of positron-emission tomography-computed tomography in preoperative staging for nonsmall-cell lung cancer with resected monometastatic disease.Medicine (Baltimore). 2019 Aug;98(33):e16843. doi: 10.1097/MD.0000000000016843. Medicine (Baltimore). 2019. PMID: 31415409 Free PMC article.
-
Effectiveness of 18F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies.BMC Cancer. 2019 Apr 5;19(1):323. doi: 10.1186/s12885-019-5488-5. BMC Cancer. 2019. PMID: 30953476 Free PMC article.
-
Health economic evaluations of medical devices in the People's Republic of China: A systematic literature review.Clinicoecon Outcomes Res. 2015 Apr 9;7:195-204. doi: 10.2147/CEOR.S78752. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 25914551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical